Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Return on Assets (2016 - 2025)

Historic Return on Assets for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to 0.6%.

  • BioCorRx's Return on Assets rose 82300.0% to 0.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6%, marking a year-over-year increase of 82300.0%. This contributed to the annual value of 13.45% for FY2024, which is 69300.0% down from last year.
  • Latest data reveals that BioCorRx reported Return on Assets of 0.6% as of Q3 2025, which was up 82300.0% from 0.74% recorded in Q2 2025.
  • Over the past 5 years, BioCorRx's Return on Assets peaked at 0.6% during Q3 2025, and registered a low of 11.32% during Q1 2024.
  • For the 5-year period, BioCorRx's Return on Assets averaged around 5.32%, with its median value being 5.25% (2022).
  • As far as peak fluctuations go, BioCorRx's Return on Assets tumbled by -53000bps in 2024, and later soared by 100900bps in 2025.
  • Quarter analysis of 5 years shows BioCorRx's Return on Assets stood at 4.39% in 2021, then fell by -26bps to 5.52% in 2022, then tumbled by -48bps to 8.17% in 2023, then fell by -24bps to 10.13% in 2024, then soared by 94bps to 0.6% in 2025.
  • Its Return on Assets stands at 0.6% for Q3 2025, versus 0.74% for Q2 2025 and 1.34% for Q1 2025.